Gain-of-glycosylation mutations

Guillaume Vogt1, Benoît Vogt, Nadia Chuzhanova

  • 1Laboratory of Human Genetics of Infectious Diseases, INSERM, U550, Paris 75015, France. vogt@necker.fr

Insights

Certain mutations add new N-linked glycans, causing disease. These glycosylation gains are necessary and sufficient for harm, suggesting potential chemical treatments for patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Missense mutations are a significant cause of genetic disorders.
  • Novel N-linked glycosylation (NLG) is an emerging pathogenic mechanism for mutations.
  • Approximately 1.4% of missense mutations may lead to gain-of-glycosylation (GofG).

Purpose of the Study:

  • To investigate the role of GofG in disease pathogenesis.
  • To explore the potential for therapeutic interventions targeting glycosylation.

Main Methods:

  • Analysis of predicted GofG mutations.
  • In vitro chemical complementation assays using patient-derived cells.
  • Assessment of glycosylation modifiers as therapeutic agents.

Main Results:

  • Gain-of-N-linked glycosylation is a validated pathogenic mechanism for certain mutations.
  • Novel glycans can be both necessary and sufficient for the deleterious effects of mutations.
  • In vitro studies show that modulating glycosylation can rescue cellular defects.

Conclusions:

  • Gain-of-glycosylation mutations represent a distinct class of genetic defects.
  • Targeting aberrant glycosylation pathways offers a promising therapeutic strategy for affected individuals.
  • Chemical modulation of glycosylation holds potential for treating diseases caused by GofG mutations.

Related Concept Videos

Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview